search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
INFECTION PREVENTION RESOURCE GUIDE


traffi c surges can help ensure facilities are as prepared as possible for future challenges.”


As part of planning, Jon Imms, Global Technical & Product Director, CleanSpace Technology, recommends focus on respira- tory PPE. “As part of an ongoing Pandemic Pre- paredness Program, there is a clear mandate for practices around the world to prioritize the improvement of policies, procedures and equipment for PPE,” Imms stated. “While N95s have a place in the commu- nity and some clinical settings, in high-risk environments where airborne pathogens exist, such as in the COVID-19 and Ebola outbreaks, staff need to be using Powered Air Purifying Respirators (PAPRs).” Peg Fox-Giacomuzzi, MSN, BSN, RN,


National Director of Surgical Services, Standard Textile, proposes relationship building within the medical industry and development of sustainable products. “IP professionals need to be in close contact with infectious disease physicians and epidemiologists in order to stay current on what seems to be daily changes to CDC guidelines, as we continue to learn more about the COVID-19 virus,” expressed Fox-Giacomuzzi. “Looking ahead at new strategies to advance infection control and patient care, IP professionals should also advocate for increased research on sustain- able practices. All relevant stakeholders (frontline staff, linen services, vendors and IP) play a role in also understanding the value of creating a safe, sustainable culture in healthcare, and reusable textile solutions are an important part of that conversation.” Sarah Simmons, DrPH CIC FAPIC, Senior Director of Science, Xenex Disinfection Services, advocates for team collaboration, adhering to the latest disinfection standards and openness to new technology. “The COVID-19 pandemic has served to underscore the importance of teamwork between the EVS and IP teams,” Sim- mons noted. “The challenges of emerging infectious diseases will continue, and the slow but steady emergence of multi-drug resistant and pan-drug resistant bacteria will only increase in the coming years. Assuring a gold standard of environmental disinfection will be a key part of stopping the spread of these organisms. IPs and EVS Directors need to make sure they keep abreast of the newest and most effective technologies for enhanced disinfection.” In terms of education, the American Hospital Association announced earlier this year that it “received two grant awards totaling $6 million from the Centers for Disease Control and Prevention (CDC) to advance public health and infectious


disease prevention initiatives,”6 including


a “grant for $4 million,” which “will sup- port collaboration between the AHA, CDC and community colleges through Project Firstline, CDC’s national training collabora- tive for infection prevention and control… Through this initiative, current and future generations can start their careers with a more solid understanding of infection control. The initiative will also promote connections between hospitals, learning institutions and other parts of the health care system.”


Sharing observance and guidance with one another is another good practice, adds Metrex’ Ward-Fore.


“Teams can continue to collaborate with each other and share their knowledge and what they see happening on the fl oor – good or bad,” she said. “We can encourage others to speak up – if you see something that doesn’t feel right – say something. We can all help others see the importance of basic infection control by setting the good example.” HPN References at: https://hpnonline.com/21222350


« EHP TB – Kills TB in 1 minute! »


« NUGEN® NR – No-rinse Disinfection with Protection Against SARS-CoV-2 and Norovirus in a Single Step! »


Eliminate HAI-Related Pathogen Transmission in Patient/O.R. Rooms and Hospital Cafeterias/Kitchens NUGEN® EHP-TB RTU:


– A hydrogen peroxide-based cleaner and spray disinfectant with a 1 minute pathogen kill time*


– Kills TB, Norovirus, MRSA, VRSA, CRKP, Pseudomonas, HIV-1, Hepatitis B & C in 1 min.


– Low toxicity: No safety glasses required – Alcohol-free low odor technology – Kills SARS-CoV-2 in 30 sec.


NUGEN® NR No-Rinse Food Contact Surface Disinfectant Wipes:


– No water-rinse required on food contact surfaces even after disinfection – Featured on EPA’s List-N as effective against SARS-CoV-2 – Broad microbial efficacy: Kills 14 pathogens including Norovirus in 5 min.**


– Helps reduce risk of surface cross-contamination – NSF D2, EPA and California registered – Lowest toxicity: No PPE required


*Refer to EPA registration # 6836-442 for complete list of pathogens **Refer to EPA registration # 6836-379 for complete list of pathogens


Hygiene@lonza.com 1-800-365-TECH (8324)


microbialmanagement.lonza.com/hygiene


Use biocides safely. Review and follow all product label and safety instructions. All information in this presentation corresponds to Lonza’s knowledge on the subject at the date of publication, but Lonza makes no warranty as to its accuracy or completeness and Lonza assumes no obligation to update it. All information in this presentation is intended for use by recipients experienced and knowledgeable in the field, who are capable of and responsible for independently determining the suitability and to ensure their compliance with applicable law. Proper use of this information is the sole responsibility of the recipient. Republication of this information or related statements is prohibited. Information provided in this presentation by Lonza is not intended and should not be construed as a license to operate under or a recommendation to infringe any patent or other intellectual property right. All trademarks belong to Lonza or its affiliates or to their respective third parties and are used here only for informational purposes. Copyrighted material has been produced with permissions or under license, all other materials © 2021 Lonza.


hpnonline.com • HEALTHCARE PURCHASING NEWS • June 2021 37

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66